EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients

Camille Louvrier iD, Nadia Nathan iD, Vincent Cottin iD, Tifenn Desroziers, Valérie Nau, Yohan Soreze, Florence Dastot-Le Moal, Philippe Reix, Diane Bouvry, Caroline Thumerelle, Martine Reynaud-Gaubert, Alice Hadchouel und 9 weitere

Respirology · 2026

DOI: 10.1111/resp.70132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology, 2026. Verfasst von Camille Louvrier und 20 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Department, Armand Trousseau Hospital, Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Molecular Genetics Unit, Paris,…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Interstitial lung diseases ( ILDs ) are rare and severe respiratory conditions that may ultimately result in pulmonary fibrosis ( PF ). The objective of this study was to present the results of molecular diagnosis of early‐onset ILD (from neonates to young adults < 50 years) in a reference genetic diagnostic laboratory.

Methods

DNAs from 699 index cases and 190 relatives were studied over 6 years by Sanger and/or targeted next generation sequencing of surfactant‐related genes and other genes involved in early‐onset ILD .

Results

Pathogenic/likely pathogenic variants were evidenced for 62 patients (8.9%). The genes most frequently involved were SFTPA2 (13/62), followed by ABCA3 (12/62) and SFTPC (10/62). Among index cases for whom precise clinical data were available ( n = 542), indications associated with a high molecular diagnostic yield were pulmonary alveolar proteinosis (61.5%, 8/13; p < 0.0007); family history of ILD / PF and lung cancer (36.8%, 7/19; p = 0.0132) and newborns > 32 weeks gestation with neonatal respiratory distress (14.8%, 9/61). The proportion of positive molecular investigations culminated in two age groups over the lifespan: 23.3% (7/30) in children aged 1 to 10 years, and 18.3% (15/82) in adults aged 30 to 40 years. Over the 6‐year period, 190 relatives were subjected to testing in order to perform segregation studies ( n = 123) and/or predictive testing ( n = 79).

Conclusion

This study highlights the specific patient's characteristics associated with a high or low molecular diagnostic yield in clinical practice. Furthermore, it emphasises the importance of establishing a molecular diagnosis in order to provide genetic counselling to the family.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialHumansFemaleMaleAdultMiddle AgedAdolescentChildInfant, NewbornInfantChild, PreschoolYoung AdultAge of OnsetPulmonary Surfactant-Associated Protein CHigh-Throughput Nucleotide SequencingPulmonary Alveolar ProteinosisATP-Binding Cassette Transporters

Stichwörter der Autor:innen

geneticsinterstitial lung diseasepulmonary fibrosissurfactant

Substanzen

ABCA3 protein, humanPulmonary Surfactant-Associated Protein CATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Medical Genetics Department, Armand Trousseau Hospital, Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Molecular Genetics Unit, Paris, France.
  • Sorbonne Université, Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Paris, France.
  • Pediatric Pulmonology Department and Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, Hospices Civils de Lyon, Université Lyon 1, UMR754, INRAE, ERN-LUNG, Lyon, France.
  • Assistance Publique Hôpitaux de Paris, Intensive Care Unit, Armand Trousseau Hospital, Paris, France.
  • Pediatric Pulmonology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.

ORCID-Profile: Camille Louvrier, Nadia Nathan, Vincent Cottin, Ibrahima Ba, Raphaël Borie, Marie Legendre

Zitieren

APA

Louvrier, C., Nathan, N., Cottin, V., Desroziers, T., Nau, V., Soreze, Y., Dastot-Le Moal, F., Reix, P., Bouvry, D., Thumerelle, C., Reynaud-Gaubert, M., Hadchouel, A., Prévot, G., Manali, E., Kannengiesser, C., Ba, I., Amselem, S., Houdouin, V., Borie, R., …, & RespiRare and OrphaLung (2026). Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients. Respirology. https://doi.org/10.1111/resp.70132

Vancouver

Louvrier C, Nathan N, Cottin V, Desroziers T, Nau V, Soreze Y, et al. Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients. Respirology. 2026. doi:10.1111/resp.70132

BibTeX
@article{Louvrier2026,
  author = {Louvrier, Camille and Nathan, Nadia and Cottin, Vincent and Desroziers, Tifenn and Nau, Valérie and Soreze, Yohan and Dastot-Le Moal, Florence and Reix, Philippe and Bouvry, Diane and Thumerelle, Caroline and Reynaud-Gaubert, Martine and Hadchouel, Alice and Prévot, Grégoire and Manali, Effrosyni and Kannengiesser, Caroline and Ba, Ibrahima and Amselem, Serge and Houdouin, Véronique and Borie, Raphaël and Legendre, Marie and RespiRare and OrphaLung, RespiRare and OrphaLung},
  title = {Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients},
  journal = {Respirology},
  year = {2026},
  doi = {10.1111/resp.70132}
}
Kostenlos starten →